𝔖 Bobbio Scriptorium
✦   LIBER   ✦

482 Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo xenograft model

✍ Scribed by L. Maggiorella; E. Deutsch; V. Frascogna; J. Bourthis

Book ID
118620656
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
169 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Seliciclib (CYC202, R-roscovitine) enhan
Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model
✍ Maria Virginia C.L. Appleyard; Mary A. O'Neill; Karen E. Murray; Fiona E.M. Paul πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 503 KB

## Abstract We sought to determine whether seliciclib (CYC202, R‐roscovitine) could increase the antitumor effects of doxorubicin, with no increase in toxicity, in an MCF7 breast cancer xenograft model. The efficacy of seliciclib combined with doxorubicin was compared with single agent doxorubicin

Schedule-dependent radiation enhancement
Schedule-dependent radiation enhancement by paclitaxel with accelerated fractionated radiation in a human squamous carcinoma xenograft
✍ Marion A. Joschko; Lorraine K. Webster; Janice Groves; Kally Yuen; James F. Bish πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 661 KB

Paclitaxel is a microtubule inhibitor that blocks cells in G,M, the most radiosensitive phase of the cell cycle. Thus paclitaxel may be therapeutically useful in combination with radiation. The purpose of this study was to determine whether paclitaxel in different schedules could enhance radiation-i

Enhancement of radiation-induced regrowt
Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model
✍ Marion A. Joschko; Lorraine K. Webster; Janice Groves; Kally Yuen; Manuela Palat πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 545 KB

Gemcitabine, a cytidine nucleoside analogue, has schedule-dependent antitumor activity in vitro and in vivo. Gemcitabine also has dose-and time-dependent radiosensitization properties in vitro. Thus it may have therapeutic application in combination with radiation. The aims of this study were to inv